![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Slc9b2 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Slc9b2 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of SLC9B2 mRNA | CTD | PMID:17555576 | Slc9b2 | Rat | 17beta-estradiol | increases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of SLC9B2 mRNA | CTD | PMID:31614463 | Slc9b2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slc9b2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC9B2 mRNA | CTD | PMID:21570461 | Slc9b2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC9B2 mRNA | CTD | PMID:33387578 | Slc9b2 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | Slc9b2 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of SLC9B2 mRNA | CTD | PMID:28959563 | Slc9b2 | Rat | acrylamide | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of SLC9B2 mRNA | CTD | PMID:32763439 | Slc9b2 | Rat | aflatoxin B1 | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of SLC9B2 mRNA | CTD | PMID:21632981 | Slc9b2 | Rat | aflatoxin B1 | increases methylation | ISO | SLC9B2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of SLC9B2 intron | CTD | PMID:30157460 | Slc9b2 | Rat | aflatoxin B1 | decreases methylation | ISO | SLC9B2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SLC9B2 gene | CTD | PMID:27153756 | Slc9b2 | Rat | Aflatoxin B2 alpha | increases methylation | ISO | SLC9B2 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of SLC9B2 intron | CTD | PMID:30157460 | Slc9b2 | Rat | all-trans-retinoic acid | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SLC9B2 mRNA | CTD | PMID:33167477 | Slc9b2 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SLC9B2 mRNA | CTD | PMID:35163327 | Slc9b2 | Rat | atrazine | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of SLC9B2 mRNA | CTD | PMID:22378314 | Slc9b2 | Rat | belinostat | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | belinostat results in decreased expression of SLC9B2 mRNA | CTD | PMID:26272509 and PMID:27188386 | Slc9b2 | Rat | belinostat | multiple interactions | ISO | SLC9B2 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC9B2 mRNA | CTD | PMID:27188386 | Slc9b2 | Rat | benzo[a]pyrene | increases expression | ISO | Slc9b2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SLC9B2 mRNA | CTD | PMID:22228805 | Slc9b2 | Rat | benzo[a]pyrene | affects methylation | ISO | SLC9B2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SLC9B2 intron | CTD | PMID:30157460 | Slc9b2 | Rat | benzo[e]pyrene | increases methylation | ISO | SLC9B2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of SLC9B2 intron | CTD | PMID:30157460 | Slc9b2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC9B2 mRNA | CTD | PMID:25181051 more ... | Slc9b2 | Rat | bisphenol A | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of SLC9B2 mRNA | CTD | PMID:31715268 | Slc9b2 | Rat | bisphenol A | increases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of SLC9B2 mRNA | CTD | PMID:29275510 | Slc9b2 | Rat | caffeine | decreases phosphorylation | ISO | SLC9B2 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of SLC9B2 protein | CTD | PMID:35688186 | Slc9b2 | Rat | carbon nanotube | increases expression | ISO | Slc9b2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Slc9b2 | Rat | copper(II) sulfate | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SLC9B2 mRNA | CTD | PMID:19549813 | Slc9b2 | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of SLC9B2 mRNA | CTD | PMID:26577399 | Slc9b2 | Rat | dorsomorphin | multiple interactions | ISO | SLC9B2 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Slc9b2 | Rat | doxorubicin | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SLC9B2 mRNA | CTD | PMID:29803840 | Slc9b2 | Rat | entinostat | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | entinostat results in decreased expression of SLC9B2 mRNA | CTD | PMID:26272509 and PMID:27188386 | Slc9b2 | Rat | entinostat | multiple interactions | ISO | SLC9B2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC9B2 mRNA | CTD | PMID:27188386 | Slc9b2 | Rat | gallic acid | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Gallic Acid results in decreased expression of SLC9B2 mRNA | CTD | PMID:34408198 | Slc9b2 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SLC9B2 mRNA | CTD | PMID:33387578 | Slc9b2 | Rat | glycidol | decreases expression | EXP | | 6480464 | glycidol results in decreased expression of SLC9B2 mRNA | CTD | PMID:24915197 | Slc9b2 | Rat | lithium atom | multiple interactions | ISO | SLC9B2 (Homo sapiens) | 6480464 | SLC9B2 protein affects the transport of [Sodium co-treated with Lithium] | CTD | PMID:18000046 | Slc9b2 | Rat | lithium hydride | multiple interactions | ISO | SLC9B2 (Homo sapiens) | 6480464 | SLC9B2 protein affects the transport of [Sodium co-treated with Lithium] | CTD | PMID:18000046 | Slc9b2 | Rat | methapyrilene | increases methylation | ISO | SLC9B2 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of SLC9B2 intron | CTD | PMID:30157460 | Slc9b2 | Rat | nickel atom | increases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Nickel results in increased expression of SLC9B2 mRNA | CTD | PMID:24768652 | Slc9b2 | Rat | panobinostat | multiple interactions | ISO | SLC9B2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC9B2 mRNA | CTD | PMID:27188386 | Slc9b2 | Rat | panobinostat | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | panobinostat results in decreased expression of SLC9B2 mRNA | CTD | PMID:26272509 | Slc9b2 | Rat | paracetamol | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SLC9B2 mRNA | CTD | PMID:25704631 | Slc9b2 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SLC9B2 mRNA | CTD | PMID:35163327 | Slc9b2 | Rat | phenylmercury acetate | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of SLC9B2 mRNA | CTD | PMID:26272509 | Slc9b2 | Rat | phenylmercury acetate | multiple interactions | ISO | SLC9B2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC9B2 mRNA | CTD | PMID:27188386 | Slc9b2 | Rat | phloretin | decreases activity | ISO | SLC9B2 (Homo sapiens) | 6480464 | Phloretin results in decreased activity of SLC9B2 protein | CTD | PMID:18000046 | Slc9b2 | Rat | pravastatin | affects expression | EXP | | 6480464 | Pravastatin affects the expression of SLC9B2 mRNA | CTD | PMID:27225895 | Slc9b2 | Rat | pravastatin | increases expression | ISO | Slc9b2 (Mus musculus) | 6480464 | Pravastatin results in increased expression of SLC9B2 mRNA | CTD | PMID:27225895 | Slc9b2 | Rat | SB 431542 | multiple interactions | ISO | SLC9B2 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Slc9b2 | Rat | silver atom | decreases expression | ISO | Slc9b2 (Mus musculus) | 6480464 | Silver results in decreased expression of SLC9B2 mRNA | CTD | PMID:27131904 | Slc9b2 | Rat | silver(0) | decreases expression | ISO | Slc9b2 (Mus musculus) | 6480464 | Silver results in decreased expression of SLC9B2 mRNA | CTD | PMID:27131904 | Slc9b2 | Rat | sodium arsenite | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of SLC9B2 mRNA | CTD | PMID:38568856 | Slc9b2 | Rat | sodium arsenite | decreases expression | ISO | Slc9b2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of SLC9B2 mRNA | CTD | PMID:37682722 | Slc9b2 | Rat | sodium atom | multiple interactions | ISO | SLC9B2 (Homo sapiens) | 6480464 | SLC9B2 protein affects the transport of [Sodium co-treated with Lithium] | CTD | PMID:18000046 | Slc9b2 | Rat | sodium chloride | affects abundance | ISO | SLC9B2 (Homo sapiens) | 6480464 | SLC9B2 protein affects the abundance of Sodium Chloride | CTD | PMID:18000046 | Slc9b2 | Rat | succimer | multiple interactions | ISO | Slc9b2 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC9B2 mRNA | CTD | PMID:21641980 | Slc9b2 | Rat | sunitinib | increases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of SLC9B2 mRNA | CTD | PMID:31533062 | Slc9b2 | Rat | tamoxifen | affects expression | ISO | Slc9b2 (Mus musculus) | 6480464 | Tamoxifen affects the expression of SLC9B2 mRNA | CTD | PMID:17555576 | Slc9b2 | Rat | tamoxifen | decreases expression | ISO | Slc9b2 (Mus musculus) | 6480464 | Tamoxifen results in decreased expression of SLC9B2 mRNA | CTD | PMID:25123088 | Slc9b2 | Rat | thiram | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Thiram results in decreased expression of SLC9B2 mRNA | CTD | PMID:38568856 | Slc9b2 | Rat | titanium dioxide | decreases expression | ISO | Slc9b2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of SLC9B2 mRNA | CTD | PMID:29264374 | Slc9b2 | Rat | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of SLC9B2 mRNA | CTD | PMID:33387578 | Slc9b2 | Rat | trichostatin A | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of SLC9B2 mRNA | CTD | PMID:24935251 | Slc9b2 | Rat | triphenyl phosphate | affects expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of SLC9B2 mRNA | CTD | PMID:37042841 | Slc9b2 | Rat | valproic acid | affects expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SLC9B2 mRNA | CTD | PMID:25979313 | Slc9b2 | Rat | valproic acid | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SLC9B2 mRNA | CTD | PMID:23179753 more ... | Slc9b2 | Rat | valproic acid | multiple interactions | ISO | SLC9B2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC9B2 mRNA | CTD | PMID:27188386 | Slc9b2 | Rat | vorinostat | decreases expression | ISO | SLC9B2 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of SLC9B2 mRNA | CTD | PMID:27188386 | Slc9b2 | Rat | zaragozic acid A | decreases expression | EXP | | 6480464 | squalestatin 1 results in decreased expression of SLC9B2 mRNA | CTD | PMID:27225895 | Slc9b2 | Rat | zaragozic acid A | affects expression | ISO | Slc9b2 (Mus musculus) | 6480464 | squalestatin 1 affects the expression of SLC9B2 mRNA | CTD | PMID:27225895 | |